Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review

ABSTRACT:

Background

Global annual cancer incidence is forecast to rise to 27.5 M by 2040, a 62% increase from 2018. For most cancers, prevention and early detection are the most effective ways of reducing mortality. This study maps trials in cancer screening, prevention, and early diagnosis (SPED) to identify areas of unmet need and highlight research priorities.

Methods

A systematic mapping review was conducted to evaluate all clinical trials focused on cancer SPED, irrespective of tumour type. The National Cancer Research Institute (NCRI) portfolio, EMBASE, PubMed and Medline were searched for relevant papers published between 01/01/2007 and 01/04/2020. References were exported into Covidence software and double-screened. Data were extracted and mapped according to tumour site,

SUBMITTER: O’Dowd E 

PROVIDER: S-EPMC10476302 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature